Receptor T-Cell Chimeric Antigen Approach Used for the Prediction Model Treatment for Relapsed/Refractory Multiple Myeloma

被引：1
|
作者：
Yin, Zhao [1 ]
Zhang, Qing [1 ]
Ou, Ruiming [1 ]
Liu, Shuang [1 ]
机构：
[1] Guangdong Second Prov Gen Hosp, Dept Hematol, Guangzhou, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 25期
关键词：
D O I：
10.1200/JCO.24.00544
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Impact of Previous Allogeneic Hematopoietic Stem Cell Transplantation on Chimeric Antigen Receptor (CAR) T Cell Treatment for Relapsed/Refractory Multiple Myeloma
    Kirchberg, Janine
    Fischer, Luise
    Born, Patrick
    Brunner, Franziska
    Morgner, Charlotte
    Fuerst, Daniel
    Heyn, Simone
    Bach, Enrica
    Brueckner, Mandy
    Jentzsch, Madlen
    Wang, Song-Yau
    Boettcher, Sebastian
    Franke, Georg-Nikolaus
    Schrezenmeier, Hubert
    Platzbecker, Uwe
    Merz, Maximilian
    Vucinic, Vladan
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 (09): : e277 - e282
  • [32] Proposed clinical factors scoring system for chimeric antigen receptor T-cell (CAR T) patient selection in relapsed and refractory multiple myeloma (RRMM)
    Faiman, Beth
    Valent, Jason
    Khouri, Jack
    Williams, Louis
    Samaras, Christy J.
    Mazzoni, Sandy
    Sobecks, Ronald
    Scott, Cynthia
    Hamilton, Kimberly
    Schlueter, Kristen
    Sgobbo, Josephine
    Krieger, Katie
    Chiancone, Lisa
    Healy, Amy
    Cross, Kerry
    Ostrowski, Jennifer
    Coffman, Julie
    Hamilton, Betty
    Sauter, Craig
    Caimi, Paolo
    Anwer, Faiz
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S39 - S40
  • [33] Impact of Frailty on Outcomes after Chimeric Antigen Receptor T Cell Therapy for Patients with Relapsed/Refractory Multiple Myeloma
    Davis, James A.
    Dima, Danai
    Ahmed, Nausheen
    Dejarnette, Shaun
    McGuirk, Joseph
    Jia, Xuefei
    Raza, Shahzad
    Khouri, Jack
    Valent, Jason
    Anwer, Faiz
    Abdallah, Al-Ola
    Hashmi, Hamza
    TRANSPLANTATION AND CELLULAR THERAPY, 2024, 30 (03): : 298 - 305
  • [34] Cytomegalovirus Retinitis and Retinal Detachment following Chimeric Antigen Receptor T Cell Therapy for Relapsed/Refractory Multiple Myeloma
    Zu, Cheng
    Xu, Yufeng
    Wang, Yiyun
    Zhang, Mingming
    Zhao, Houli
    Fang, Xiaoyun
    Huang, He
    Hu, Yongxian
    CURRENT ONCOLOGY, 2022, 29 (02) : 490 - 496
  • [35] A successful haploidentical transplantation without conditioning regimen for a relapsed/refractory multiple myeloma patient after chimeric antigen receptor T-cell therapy
    Dai, Zigang
    Yu, Nanzhou
    Cao, Yang
    Zhou, Jianfeng
    Zhang, Yicheng
    Wang, Na
    Zhou, Xiaoxi
    CYTOTHERAPY, 2025, 27 (03) : 295 - 299
  • [36] Real-world applicability of commercial chimeric antigen receptor T-cell therapy among older adults with relapsed and/or refractory multiple myeloma
    Giri, Smith
    Bal, Susan
    Godby, Kelly N.
    Ravi, Gayathri
    Clark, Deanna
    Ubersax, Clare
    Cooley, Abigail
    White, Priscila
    Rangarajan, Sunil
    Williams, Grant R.
    Costa, Luciano J.
    AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 (04) : E153 - E155
  • [37] Associations of granulocyte colony-stimulating factor with toxicities and efficacy of chimeric antigen receptor T-cell therapy in relapsed or refractory multiple myeloma
    Ma, Sha
    Li, Hujun
    Zhou, Dian
    Zhang, Xiaotian
    Shi, Ming
    Cao, Jiang
    Qi, Yuekun
    Xia, Jieyun
    Liu, Yang
    Wang, Xue
    Li, Depeng
    Sang, Wei
    Yan, Zhiling
    Zhu, Feng
    Sun, Haiying
    Cheng, Hai
    Zheng, Junnian
    Xu, Kailin
    Li, Zhenyu
    Qi, Kunmin
    Wang, Ying
    CYTOTHERAPY, 2023, 25 (06) : 653 - 658
  • [38] Incidence of acute kidney injury in patients with relapsed and refractory multiple myeloma treated with teclistamab vs chimeric antigen receptor T-cell therapy
    Charkviani, Mariam
    Vaughan, Lisa E.
    Sandahl, Tyler B.
    Lin, Yi
    Leung, Nelson
    Herrmann, Sandra M.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [39] Current Status of Chimeric Antigen Receptor T-Cell Therapy in Multiple Myeloma
    Jindal, Vishal
    Khoury, John
    Gupta, Ruby
    Jaiyesimi, Ishmael
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2020, 43 (05): : 371 - 377
  • [40] Chimeric Antigen Receptor T-Cell Therapeutics for Multiple Myeloma Moving Into the Spotlight
    Wang, Bo
    Rajeeve, Sridevi
    Madduri, Deepu
    CANCER JOURNAL, 2021, 27 (03): : 205 - 212
12345